Fresenius Medical Care AG & Co. (FMS)
(Real Time Quote from BATS)
$20.27 USD
+0.02 (0.10%)
Updated Sep 23, 2024 01:04 PM ET
3-Hold of 5 3
A Value B Growth A Momentum A VGM
Income Statements
Fiscal Year end for Fresenius Medical Care AG & Co KGaA falls in the month of December .
All items in Millions except EPS data.
12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 | |
---|---|---|---|---|---|
Sales | 21,055 | 20,438 | 20,845 | 20,400 | 19,574 |
Cost Of Goods | 15,724 | 14,843 | 14,838 | 14,075 | 13,530 |
Gross Profit | 5,330 | 5,595 | 6,007 | 6,325 | 6,043 |
Selling & Adminstrative & Depr. & Amort Expenses | 3,848 | 4,002 | 3,815 | 3,693 | 3,501 |
Income After Depreciation & Amortization | 1,482 | 1,593 | 2,191 | 2,632 | 2,542 |
Non-Operating Income | 95 | 71 | 87 | 48 | 69 |
Interest Expense | 460 | 379 | 418 | 468 | 550 |
Pretax Income | 1,118 | 1,285 | 1,860 | 2,212 | 2,061 |
Income Taxes | 325 | 342 | 417 | 572 | 450 |
Minority Interest | 253 | 233 | 295 | 310 | 268 |
Investment Gains/Losses | 0 | 0 | 0 | 0 | 0 |
Other Income/Charges | 0 | 0 | 0 | 0 | 0 |
Income From Cont. Operations | 793 | 942 | 1,442 | 1,640 | 1,611 |
Extras & Discontinued Operations | 0 | 0 | 0 | 0 | 0 |
Net Income (GAAP) | 540 | 710 | 1,147 | 1,330 | 1,344 |
Depreciation Footnote | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Income Before Depreciation & Amortization | 3,378 | 3,530 | 4,112 | 4,672 | 4,326 |
Depreciation & Amortization (Cash Flow) | 1,896 | 1,937 | 1,921 | 2,040 | 1,784 |
Income After Depreciation & Amortization | 1,482 | 1,593 | 2,191 | 2,632 | 2,542 |
Earnings Per Share Data | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Average Shares | 586.83 | 586.49 | 585.89 | 588.11 | 605.38 |
Diluted EPS Before Non-Recurring Items | 1.39 | 1.64 | 2.06 | 2.64 | 2.53 |
Diluted Net EPS (GAAP) | 0.92 | 1.21 | 1.96 | 2.26 | 2.22 |
Fiscal Year end for Fresenius Medical Care AG & Co KGaA falls in the month of December .
All items in Millions except EPS data.
6/30/24 | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | |
---|---|---|---|---|---|
Sales | 5,132.98 | 5,129.41 | 5,371.06 | 5,372.60 | 5,261.48 |
Cost Of Goods | 3,876.79 | 3,855.18 | 3,917.30 | 4,034.96 | 3,956.04 |
Gross Profit | 1,256.19 | 1,274.23 | 1,453.77 | 1,337.64 | 1,305.44 |
SG&A, R&D, and Dept/Amort Expenses | 798.74 | 1,007.14 | 993.47 | 984.75 | 916.57 |
Income After SG&A, R&D, and Dept/Amort Expenses | 457.45 | 267.09 | 460.30 | 352.89 | 388.87 |
Non-Operating Income | 19.11 | 17.01 | 28.84 | 27.36 | 26.31 |
Interest Expense | 111.00 | 112.75 | 119.93 | 123.92 | 114.14 |
Pretax Income | 365.56 | 171.35 | 369.20 | 256.33 | 301.04 |
Income Taxes | 106.63 | 42.90 | 92.77 | 96.27 | 88.47 |
Minority Interest | 57.52 | 51.41 | 73.92 | 68.25 | 59.52 |
Investment Gains/Losses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Income/Charges | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Income From Cont. Operations | 258.94 | 128.45 | 276.43 | 160.06 | 212.57 |
Extras & Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Income (GAAP) | 201.41 | 77.04 | 202.51 | 91.81 | 153.05 |
Earnings Per Share Data | 6/30/24 | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 |
---|---|---|---|---|---|
Average Shares | 586.83 | 591.67 | 586.83 | 586.83 | 586.83 |
Diluted EPS Before Non-Recurring Items | 0.38 | 0.36 | 0.47 | 0.31 | 0.32 |
Diluted Net EPS (GAAP) | 0.34 | 0.13 | 0.34 | 0.16 | 0.26 |